{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:32:38Z","timestamp":1792675958460,"version":"4.5.0"},"publisher-location":"Berlin, Heidelberg","reference-count":251,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642216480","type":"print"},{"value":"9783642216497","type":"electronic"}],"license":[{"start":{"date-parts":[[2011,9,21]],"date-time":"2011-09-21T00:00:00Z","timestamp":1316563200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-3-642-21649-7_17","type":"book-chapter","created":{"date-parts":[[2011,10,18]],"date-time":"2011-10-18T18:39:24Z","timestamp":1318963164000},"page":"297-335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Fragile X Syndrome and Targeted Treatment Trials"],"prefix":"10.1007","author":[{"given":"Randi","family":"Hagerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Lauterborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacky","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Berry-Kravis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,21]]},"reference":[{"key":"17_CR2_17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/1675","volume":"20","author":"K Allen","year":"1998","unstructured":"Allen K, Gleeson J et al (1998) PAK3 mutation in nonsyndromic X-linked mental retardation. Nat Genet 20:25\u201330","journal-title":"Nat Genet"},{"issue":"1","key":"17_CR3_17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jecp.2009.11.003","volume":"106","author":"TP Alloway","year":"2010","unstructured":"Alloway TP, Alloway RG (2010) Investigating the predictive roles of working memory and IQ in academic attainment. J Exp Child Psychol 106(1):20\u201329","journal-title":"J Exp Child Psychol"},{"issue":"4","key":"17_CR4_17","first-page":"143","volume":"4","author":"RN Amaria","year":"2001","unstructured":"Amaria RN, Billeisen LL et al (2001) Medication use in fragile X syndrome. Mental Health Asp Dev Dis 4(4):143\u2013147","journal-title":"Mental Health Asp Dev Dis"},{"key":"17_CR5_17","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1523\/JNEUROSCI.0099-04.2004","volume":"24","author":"L Antar","year":"2004","unstructured":"Antar L, Afroz R et al (2004) Metabotropic glutamate receptor activation regulates fragile X mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses. J Neurosci 24:2648\u20132655","journal-title":"J Neurosci"},{"key":"17_CR6_17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mcn.2006.02.001","volume":"32","author":"L Antar","year":"2006","unstructured":"Antar L, Li C et al (2006) Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses. Mol Cell Neurosci 32:37\u201348","journal-title":"Mol Cell Neurosci"},{"key":"17_CR7_17","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1073\/pnas.0409803102","volume":"102","author":"A Aschrafi","year":"2005","unstructured":"Aschrafi A, Cunningham B et al (2005) The fragile X mental retardation protein and group I metabotropic glutamate receptors regulate levels of mRNA granules in brain. Proc Natl Acad Sci USA 102:2180\u20132185","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR8_17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/1096-8628(20001113)95:2<150::AID-AJMG11>3.0.CO;2-1","volume":"95","author":"M Backes","year":"2000","unstructured":"Backes M, Gen\u00e7 B et al (2000) Cognitive and behavioral profile of fragile X boys: correlations to molecular data. Am J Med Genet 95:150\u2013156","journal-title":"Am J Med Genet"},{"issue":"11","key":"17_CR9_17","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1364-6613(00)01538-2","volume":"4","author":"A Baddeley","year":"2000","unstructured":"Baddeley A (2000) The episodic buffer: a new component of working memory? Trends Cogn Sci 4(11):417\u2013423","journal-title":"Trends Cogn Sci"},{"issue":"1","key":"17_CR10_17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1365-2788.2010.01343.x","volume":"55","author":"S Baker","year":"2011","unstructured":"Baker S, Hooper S et al (2011) Working memory subsystems and task complexity in young boys with Fragile X syndrome. J Intellect Disabil Res 55(1):19\u201329","journal-title":"J Intellect Disabil Res"},{"key":"17_CR11_17","first-page":"23","volume":"78","author":"C Bakker","year":"1994","unstructured":"Bakker C, D.-B. F. X. Consortium (1994) FMR1 knockout mice: a model to study fragile X mental retardation. Cell 78:23\u201333","journal-title":"Cell"},{"key":"17_CR12_17","first-page":"63","volume-title":"Child psychopathology","author":"RA Barkley","year":"1996","unstructured":"Barkley RA (1996) Attention-deficit=hyperactivity disorder. In: Mash EJ, Barkley RA (eds) Child psychopathology. Guilford, New York, pp 63\u2013112"},{"issue":"2","key":"17_CR13_17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuron.2008.10.004","volume":"60","author":"GJ Bassell","year":"2008","unstructured":"Bassell GJ, Warren ST (2008) Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 60(2):201\u2013214","journal-title":"Neuron"},{"issue":"7","key":"17_CR14_17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.tins.2004.04.009","volume":"27","author":"MF Bear","year":"2004","unstructured":"Bear MF, Huber KM et al (2004) The mGluR theory of fragile X mental retardation. Trends Neurosci 27(7):370\u2013377","journal-title":"Trends Neurosci"},{"key":"17_CR15_17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1124\/mi.8.5.8","volume":"8","author":"J Beaulieu","year":"2008","unstructured":"Beaulieu J, Caron M (2008) Looking at lithium: molecular moods and complex behaviour. Mol Interv 8:230\u2013241","journal-title":"Mol Interv"},{"issue":"6","key":"17_CR16_17","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1080\/15374416.2010.517162","volume":"39","author":"SJ Beck","year":"2010","unstructured":"Beck SJ, Hanson CA et al (2010) A controlled trial of working memory training for children and adolescents with ADHD. J Clin Child Adolesc Psychol 39(6):825\u2013836","journal-title":"J Clin Child Adolesc Psychol"},{"issue":"10","key":"17_CR17_17","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/nn1765","volume":"9","author":"MK Belmonte","year":"2006","unstructured":"Belmonte MK, Bourgeron T (2006) Fragile X syndrome and autism at the intersection of genetic and neural networks. Nat Neurosci 9(10):1221\u20131225","journal-title":"Nat Neurosci"},{"issue":"3","key":"17_CR18_17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.nurt.2010.05.011","volume":"7","author":"S Bent","year":"2010","unstructured":"Bent S, Hendren RL (2010) Improving the prediction of response to therapy in autism. Neurotherapeutics 7(3):232\u2013240","journal-title":"Neurotherapeutics"},{"issue":"6410","key":"17_CR19_17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/361315a0","volume":"361","author":"MJ Berridge","year":"1993","unstructured":"Berridge MJ (1993) Inositol trisphosphate and calcium signalling. Nature 361(6410):315\u2013325","journal-title":"Nature"},{"issue":"1","key":"17_CR20_17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/(SICI)1097-4547(19980101)51:1<41::AID-JNR4>3.0.CO;2-L","volume":"51","author":"E Berry-Kravis","year":"1998","unstructured":"Berry-Kravis E, Ciurlionis R (1998) Overexpression of fragile X gene (FMR-1) transcripts increases cAMP production in neural cells. J Neurosci Res 51(1):41\u201348","journal-title":"J Neurosci Res"},{"issue":"1","key":"17_CR21_17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/mrdd.20007","volume":"10","author":"E Berry-Kravis","year":"2004","unstructured":"Berry-Kravis E, Potanos K (2004) Psychopharmacology in fragile X syndrome \u2013 present and future. Ment Retard Dev Disabil Res Rev 10(1):42\u201348","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"5","key":"17_CR22_17","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1203\/00006450-199511000-00002","volume":"38","author":"E Berry-Kravis","year":"1995","unstructured":"Berry-Kravis E, Hicar M et al (1995) Reduced cyclic AMP production in fragile X syndrome: cytogenetic and molecular correlations. Pediatr Res 38(5):638\u2013643","journal-title":"Pediatr Res"},{"issue":"5","key":"17_CR23_17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1089\/cap.2006.16.525","volume":"16","author":"E Berry-Kravis","year":"2006","unstructured":"Berry-Kravis E, Krause SE et al (2006) Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: A controlled trial. J Child Adolesc Psychopharmacol 16(5):525\u2013540","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"17_CR24_17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/DBP.0b013e31817dc447","volume":"29","author":"E Berry-Kravis","year":"2008","unstructured":"Berry-Kravis E, Sumis A et al (2008a) Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome. J Dev Behav Pediatr 29(4):293\u2013302","journal-title":"J Dev Behav Pediatr"},{"issue":"9","key":"17_CR25_17","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s10803-008-0564-8","volume":"38","author":"E Berry-Kravis","year":"2008","unstructured":"Berry-Kravis E, Sumis A et al (2008b) Characterization of potential outcome measures for future clinical trials in fragile x syndrome. J Autism Dev Disord 38(9):1751\u20131757","journal-title":"J Autism Dev Disord"},{"issue":"4","key":"17_CR26_17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/jmg.2008.063701","volume":"46","author":"E Berry-Kravis","year":"2009","unstructured":"Berry-Kravis E, Hessl D et al (2009) A pilot open label, single dose trial of fenobam in adults with fragile X syndrome. J Med Genet 46(4):266\u2013271","journal-title":"J Med Genet"},{"issue":"6","key":"17_CR27_17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1352\/1944-7558-115.6.461","volume":"115","author":"E Berry-Kravis","year":"2010","unstructured":"Berry-Kravis E, Raspa M et al (2010) Seizures in fragile x syndrome: characteristics and comorbid diagnoses. Am J Intellect Dev Disabil 115(6):461\u2013472","journal-title":"Am J Intellect Dev Disabil"},{"issue":"3","key":"17_CR28_17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11689-011-9074-7","volume":"3","author":"E Berry-Kravis","year":"2011","unstructured":"Berry-Kravis E, Knox A et al (2011) Targeted treatments for fragile X syndrome. J Neurodev Disord 3(3):193\u2013210","journal-title":"J Neurodev Disord"},{"issue":"5","key":"17_CR29_17","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1037\/0022-006X.72.5.757","volume":"72","author":"J Biederman","year":"2004","unstructured":"Biederman J, Monuteaux MC et al (2004) Impact of executive function deficits and attention-deficit\/hyperactivity disorder (ADHD) on academic outcomes in children. J Consult Clin Psychol 72(5):757\u2013766","journal-title":"J Consult Clin Psychol"},{"key":"17_CR30_17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/1096-8628(20000814)93:4<294::AID-AJMG8>3.0.CO;2-F","volume":"93","author":"T Bienvenu","year":"2000","unstructured":"Bienvenu T, des Portes V et al (2000) Missense mutation in PAK3, R67C, causes X-linked nonspecific mental retardation. Am J Med Genet 93:294\u2013298","journal-title":"Am J Med Genet"},{"key":"17_CR31_17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1471-4159.2006.03701.x","volume":"97","author":"T Bilousova","year":"2006","unstructured":"Bilousova T, Rusakov D et al (2006) Matrix metalloproteinase-7 disrupts dendritic spines in hippocampal neurons through NMDA receptor activation. J Neurochem 97:44\u201356","journal-title":"J Neurochem"},{"key":"17_CR32_17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1136\/jmg.2008.061796","volume":"46","author":"T Bilousova","year":"2009","unstructured":"Bilousova T, Dansie L et al (2009) Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. J Med Genet 46:94\u2013102","journal-title":"J Med Genet"},{"key":"17_CR33_17","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/nn.2175","volume":"11","author":"F Bolduc","year":"2008","unstructured":"Bolduc F, Bell K et al (2008) Excess protein synthesis in Drosophila fragile X mutants impairs long-term memory. Nat Neurosci 11:1143\u20131145","journal-title":"Nat Neurosci"},{"key":"17_CR34_17","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/cercor\/10.10.1045","volume":"10","author":"K Braun","year":"2000","unstructured":"Braun K, Segal M (2000) FMRP involvement in formation of synapses among cultured hippocampal neurons. Cereb Cortex 10:1045\u20131052","journal-title":"Cereb Cortex"},{"key":"17_CR35_17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/BF02212191","volume":"18","author":"JD Bregman","year":"1988","unstructured":"Bregman JD, Leckman JF et al (1988) Fragile X syndrome: Genetic predisposition to psychopathology. J Autism Dev Disord 18:343\u2013354","journal-title":"J Autism Dev Disord"},{"issue":"Suppl 3","key":"17_CR36_17","first-page":"S230","volume":"36","author":"T Bschor","year":"2003","unstructured":"Bschor T, Lewitzka U et al (2003) Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms. Pharmacopsychiatry 36(Suppl 3):S230\u2013234","journal-title":"Pharmacopsychiatry"},{"issue":"8","key":"17_CR37_17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrn896","volume":"3","author":"FX Castellanos","year":"2002","unstructured":"Castellanos FX, Tannock R (2002) Neuroscience of attention-deficit\/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 3(8):617\u2013628","journal-title":"Nat Rev Neurosci"},{"key":"17_CR38_17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nchembio.78","volume":"4","author":"S Chang","year":"2008","unstructured":"Chang S, Bray S et al (2008) Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. Nat Chem Biol 4:256\u2013263","journal-title":"Nat Chem Biol"},{"key":"17_CR39_17","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S0306-4522(01)00036-7","volume":"103","author":"L Chen","year":"2001","unstructured":"Chen L, Toth M (2001) Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience 103:1043\u20131050","journal-title":"Neuroscience"},{"key":"17_CR40_17","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/80538","volume":"6","author":"M Chen","year":"2000","unstructured":"Chen M, Ona V et al (2000) Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6:797\u2013801","journal-title":"Nat Med"},{"issue":"33","key":"17_CR41_17","doi-asserted-by":"publisher","first-page":"10977","DOI":"10.1523\/JNEUROSCI.1077-10.2010","volume":"30","author":"LY Chen","year":"2010","unstructured":"Chen LY, Rex CS et al (2010) Physiological activation of synaptic Rac>PAK (p-21 activated kinase) signaling is defective in a mouse model of fragile X syndrome. J Neurosci 30(33):10977\u201310984","journal-title":"J Neurosci"},{"key":"17_CR42_17","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1038\/sj.npp.1301377","volume":"32","author":"Y Choi","year":"2007","unstructured":"Choi Y, Kim H et al (2007) Minocycline attenuates neuronal cell death and improves cognitive impairment in Alzheimer's disease models. Neuropsychopharmacology 32:2393\u20132404","journal-title":"Neuropsychopharmacology"},{"key":"17_CR43_17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.brainres.2010.11.032","volume":"1380","author":"CH Choi","year":"2010","unstructured":"Choi CH, Schoenfeld BP et al (2010) Pharmacological reversal of synaptic plasticity deficits in the mouse model of Fragile X syndrome by group II mGluR antagonist or lithium treatment. Brain Res 1380:106\u2013119. doi: 10.1016\/j.brainres.2010.1011.1032","journal-title":"Brain Res"},{"issue":"1","key":"17_CR44_17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.yapd.2009.08.008","volume":"56","author":"W Chonchaiya","year":"2009","unstructured":"Chonchaiya W, Schneider A et al (2009) Fragile x: a family of disorders. Adv Pediatr 56(1):165\u2013186","journal-title":"Adv Pediatr"},{"key":"17_CR45_17","doi-asserted-by":"publisher","first-page":"8048","DOI":"10.1523\/JNEUROSCI.1777-05.2005","volume":"25","author":"S Chuang","year":"2005","unstructured":"Chuang S, Zhao W et al (2005) Prolonged epileptiform discharges induced by altered group I metabotropic glutamate receptor-mediated synaptic responses in hippocampal slices of a fragile X mouse model. J Neurosci 25:8048\u20138055","journal-title":"J Neurosci"},{"key":"17_CR46_17","first-page":"252","volume":"8","author":"I Cohen","year":"1995","unstructured":"Cohen I (1995) Behavioral profiles of autistic and non autistic fragile X males. Dev Brain Dysfunct 8:252\u2013269","journal-title":"Dev Brain Dysfunct"},{"key":"17_CR47_17","doi-asserted-by":"publisher","first-page":"5401","DOI":"10.1073\/pnas.94.10.5401","volume":"94","author":"T Comery","year":"1997","unstructured":"Comery T, Harris J et al (1997) Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci USA 94:5401\u20135404","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"17_CR48_17","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.tics.2003.10.005","volume":"7","author":"AR Conway","year":"2003","unstructured":"Conway AR, Kane MJ et al (2003) Working memory capacity and its relation to general intelligence. Trends Cogn Sci 7(12):547\u2013552","journal-title":"Trends Cogn Sci"},{"issue":"1","key":"17_CR49_17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/mrdd.20003","volume":"10","author":"KM Cornish","year":"2004","unstructured":"Cornish KM, Sudhalter V et al (2004a) Attention and language in fragile X. Ment Retard Dev Disabil Res Rev 10(1):11\u201316","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"6","key":"17_CR50_17","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/j.1469-7610.2004.t01-1-00297.x","volume":"45","author":"KM Cornish","year":"2004","unstructured":"Cornish KM, Turk J et al (2004b) Annotation: deconstructing the attention deficit in fragile X syndrome: a developmental neuropsychological approach. J Child Psychol Psychiatry 45(6):1042\u20131053","journal-title":"J Child Psychol Psychiatry"},{"key":"17_CR51_17","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1093\/cercor\/bhn159","volume":"19","author":"G Curia","year":"2008","unstructured":"Curia G, Papouin T et al (2008) Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome. Cereb Cortex 19:1515\u20131520","journal-title":"Cereb Cortex"},{"key":"17_CR52_17","doi-asserted-by":"publisher","unstructured":"Dahlin K (2010) Effects of working memory training on reading in children with special needs. Read Writ. doi: 10.1007\/s11145-11010-19238-y","DOI":"10.1007\/s11145-11010-19238-y"},{"issue":"4","key":"17_CR53_17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3758\/BF03214546","volume":"3","author":"M Daneman","year":"1996","unstructured":"Daneman M, Merikle P (1996) Working memory and language comprehension: a meta-analysis. Psychon Bull Rev 3(4):422\u2013433","journal-title":"Psychon Bull Rev"},{"issue":"8","key":"17_CR54_17","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1101\/gad.1276805","volume":"19","author":"JC Darnell","year":"2005","unstructured":"Darnell JC, Fraser CE et al (2005) Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes Dev 19(8):903\u2013918","journal-title":"Genes Dev"},{"key":"17_CR55_17","unstructured":"Darnell JC, SJ Van Driesche C et al (2011) FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism. Cell 146(2):247\u2013261"},{"key":"17_CR56_17","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/npp.2008.152","volume":"34","author":"Y Diego-Otero de","year":"2008","unstructured":"de Diego-Otero Y, Romero-Zerbo Y et al (2008) Alpha-tocopherol protects against oxidative stress in the fragile X knockout mouse: an experimental therapeutic approach for the Fmr1 deficiency. Neuropsychopharmacology 34:1011\u20131026","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"17_CR57_17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.nurt.2010.05.001","volume":"7","author":"PJ Vries de","year":"2010","unstructured":"de Vries PJ (2010) Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex. Neurotherapeutics 7(3):275\u2013282","journal-title":"Neurotherapeutics"},{"issue":"1","key":"17_CR58_17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.nbd.2008.04.002","volume":"31","author":"FM Vrij de","year":"2008","unstructured":"de Vrij FM, Levenga J et al (2008) Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice. Neurobiol Dis 31(1):127\u2013132","journal-title":"Neurobiol Dis"},{"key":"17_CR59_17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.neuropharm.2009.05.010","volume":"57","author":"K Destot-Wong","year":"2009","unstructured":"Destot-Wong K, Liang K et al (2009) The AMPA receptor positive allosteric modulator, S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis. Neuropharmacology 57:277\u2013286","journal-title":"Neuropharmacology"},{"issue":"2","key":"17_CR60_17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0306-4522(96)00224-2","volume":"76","author":"R D'Hooge","year":"1997","unstructured":"D'Hooge R, Nagels G et al (1997) Mildly impaired water maze performance in male Fmr1 knockout mice. Neuroscience 76(2):367\u2013376","journal-title":"Neuroscience"},{"key":"17_CR61_17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.brainres.2006.08.115","volume":"1121","author":"C D'Hulst","year":"2006","unstructured":"D'Hulst C, De Geest N et al (2006) Decreased expression of the GABAA receptor in fragile X syndrome. Brain Res 1121:238\u2013245","journal-title":"Brain Res"},{"issue":"2","key":"17_CR62_17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0306-4522(00)00292-X","volume":"100","author":"C Dobkin","year":"2000","unstructured":"Dobkin C, Rabe A et al (2000) Fmr1 knockout mouse has a distinctive strain-specific learning impairment. Neuroscience 100(2):423\u2013429","journal-title":"Neuroscience"},{"key":"17_CR63_17","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.neuron.2007.12.001","volume":"56","author":"G D\u00f6len","year":"2007","unstructured":"D\u00f6len G, Osterweil E et al (2007) Correction of fragile X syndrome in mice. Neuron 56:955\u2013962","journal-title":"Neuron"},{"issue":"25","key":"17_CR64_17","doi-asserted-by":"publisher","first-page":"11573","DOI":"10.1073\/pnas.0913138107","volume":"107","author":"J Du","year":"2010","unstructured":"Du J, Wei Y et al (2010) A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors. Proc Natl Acad Sci USA 107(25):11573\u201311578","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR65_17","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1111\/j.1460-9568.2007.05939.x","volume":"26","author":"R el Bekay","year":"2007","unstructured":"el Bekay R, Romero-Zerbo Y et al (2007) Enhanced markers of oxidative stress, altered antioxidants and NADPH-oxidase activation in brains from Fragile X mental retardation 1-deficient mice, a pathological model for Fragile X syndrome. Eur J Neurosci 26:3169\u20133180","journal-title":"Eur J Neurosci"},{"key":"17_CR66_17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.neulet.2004.11.087","volume":"377","author":"A El Idrissi","year":"2005","unstructured":"El Idrissi A, Ding X et al (2005) Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse. Neurosci Lett 377:141\u2013146","journal-title":"Neurosci Lett"},{"key":"17_CR67_17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/978-0-387-75681-3_19","volume":"643","author":"A El Idrissi","year":"2009","unstructured":"El Idrissi A, Boukarrou L et al (2009) Taurine improves congestive functions in a mouse model of fragile X syndrome. Adv Exp Med Biol 643:191\u2013198","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"17_CR68_17","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1044\/1092-4388(2008\/07-0210)","volume":"51","author":"PM Engel","year":"2008","unstructured":"Engel PM, Santos FH et al (2008) Are working memory measures free of socioeconomic influence? J Speech Lang Hear Res 51(6):1580\u20131587","journal-title":"J Speech Lang Hear Res"},{"key":"17_CR69_17","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s10803-009-0807-3","volume":"39","author":"CA Erickson","year":"2009","unstructured":"Erickson CA, Mullett JE et al (2009) Open-label memantine in fragile X syndrome. J Autism Dev Disord 39:1629\u20131635","journal-title":"J Autism Dev Disord"},{"issue":"11","key":"17_CR70_17","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1007\/s10803-010-0988-9","volume":"40","author":"CA Erickson","year":"2010","unstructured":"Erickson CA, Mullett JE et al (2010a) Brief report: acamprosate in fragile X syndrome. J Autism Dev Disord 40(11):1412\u20131416","journal-title":"J Autism Dev Disord"},{"issue":"3","key":"17_CR71_17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.nurt.2010.04.001","volume":"7","author":"CA Erickson","year":"2010","unstructured":"Erickson CA, Stigler KA et al (2010b) Aripiprazole in autism spectrum disorders and fragile X syndrome. Neurotherapeutics 7(3):258\u2013263","journal-title":"Neurotherapeutics"},{"key":"17_CR72_17","doi-asserted-by":"publisher","unstructured":"Erickson CA, Weng N et al (2010c) Open-label riluzole in fragile X syndrome. Brain Res. doi: 10.1016\/j.brainres.2010.1010.1108","DOI":"10.1016\/j.brainres.2010.1010.1108"},{"key":"17_CR205_17","doi-asserted-by":"crossref","unstructured":"Farzin F, F Scaggs, et al (2011) Reliability of Eye Tracking and Pupillometry Measures in Individuals with Fragile X Syndrome. J Autism Dev Disord. DOI: 10.1007\/s10803-011-1176-2","DOI":"10.1007\/s10803-011-1176-2"},{"key":"17_CR73_17","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.neuropharm.2010.11.011","volume":"60","author":"SH Fatemi","year":"2010","unstructured":"Fatemi SH, Folsom TD (2010) The role of fragile X mental retardation protein in major mental disorders.\". Neuropharmacology 60:1221\u20131226","journal-title":"Neuropharmacology"},{"issue":"1\u20133","key":"17_CR74_17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.schres.2010.07.017","volume":"124","author":"SH Fatemi","year":"2010","unstructured":"Fatemi SH, Kneeland RE et al (2010) Fragile X mental retardation protein levels are decreased in major psychiatric disorders. Schizophr Res 124(1\u20133):246\u2013247","journal-title":"Schizophr Res"},{"key":"17_CR75_17","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/sj.mp.4001432","volume":"9","author":"P Frankland","year":"2004","unstructured":"Frankland P, Wang Y et al (2004) Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice. Mol Psychiatry 9:417\u2013425","journal-title":"Mol Psychiatry"},{"issue":"2","key":"17_CR76_17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1542\/peds.91.2.321","volume":"91","author":"LS Freund","year":"1993","unstructured":"Freund LS, Reiss AL et al (1993) Psychiatric disorders associated with fragile X in the young female. Pediatrics 91(2):321\u2013329","journal-title":"Pediatrics"},{"issue":"1\u20133","key":"17_CR77_17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0301-0511(00)00051-X","volume":"54","author":"AF Fry","year":"2000","unstructured":"Fry AF, Hale S (2000) Relationships among processing speed, working memory, and fluid intelligence in children. Biol Psychol 54(1\u20133):1\u201334","journal-title":"Biol Psychol"},{"issue":"10","key":"17_CR78_17","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1021\/cn100032f","volume":"1","author":"JL Fulks","year":"2010","unstructured":"Fulks JL, O'Bryhim BE et al (2010) Dopamine release and uptake impairments and behavioral alterations observed in mice that model fragile x mental retardation syndrome. ACS Chem Neurosci 1(10):679\u2013690","journal-title":"ACS Chem Neurosci"},{"key":"17_CR79_17","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.1523\/JNEUROSCI.5407-03.2004","volume":"24","author":"S Gallagher","year":"2004","unstructured":"Gallagher S, Daly C et al (2004) Extracellular signal-regulated protein kinase activation is required for metabotropic glutamate receptor-dependent long-term depression in hippocampal area CA1. J Neurosci 24:4859\u20134864","journal-title":"J Neurosci"},{"key":"17_CR80_17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2174\/1566524013363492","volume":"1","author":"I Gantois","year":"2001","unstructured":"Gantois I, Bakker C et al (2001) Restoring the phenotype of fragile X syndrome: insight from the mouse model. Curr Mol Med 1:447\u2013455","journal-title":"Curr Mol Med"},{"key":"17_CR81_17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.nbd.2005.07.017","volume":"21","author":"I Gantois","year":"2006","unstructured":"Gantois I, Vandesompele J et al (2006) Expression profiling suggests underexpression of the GABA(A) receptor subunit delta in the fragile X knockout mouse model. Neurobiol Dis 21:346\u2013357","journal-title":"Neurobiol Dis"},{"issue":"5","key":"17_CR82_17","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1365-2214.2006.00616.x","volume":"32","author":"J Garstang","year":"2006","unstructured":"Garstang J, Wallis M (2006) Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev 32(5):585\u2013589","journal-title":"Child Care Health Dev"},{"key":"17_CR83_17","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S0028-3908(99)00082-9","volume":"38","author":"F Gasparini","year":"1999","unstructured":"Gasparini F, Lingenh\u00f6hl K et al (1999) 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology 38:1493\u20131503","journal-title":"Neuropharmacology"},{"issue":"Pt 2","key":"17_CR84_17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1348\/000709900158047","volume":"70","author":"SE Gathercole","year":"2000","unstructured":"Gathercole SE, Pickering SJ (2000) Working memory deficits in children with low achievements in the national curriculum at 7 years of age. Br J Educ Psychol 70(Pt 2):177\u2013194","journal-title":"Br J Educ Psychol"},{"key":"17_CR85_17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.53841\/bpsecp.2003.20.3.109","volume":"20","author":"SE Gathercole","year":"2003","unstructured":"Gathercole SE, Brown L et al (2003) Working memory assessments at school entry as longitudinal predictors of National Curriculum attainment levels. Educ Child Psychol 20:109\u2013122","journal-title":"Educ Child Psychol"},{"issue":"2","key":"17_CR86_17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jecp.2004.03.002","volume":"88","author":"DC Geary","year":"2004","unstructured":"Geary DC, Hoard MK et al (2004) Strategy choices in simple and complex addition: Contributions of working memory and counting knowledge for children with mathematical disability. J Exp Child Psychol 88(2):121\u2013151","journal-title":"J Exp Child Psychol"},{"key":"17_CR87_17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/138945011794182764","volume":"12","author":"AB Gold","year":"2010","unstructured":"Gold AB, Herrmann N et al (2010) Lithium and its neuroprotective and neurotrophic effects: potential treatment for post-ischemic stroke sequelae. Curr Drug Targets 12:243\u2013255","journal-title":"Curr Drug Targets"},{"key":"17_CR88_17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s002130050850","volume":"141","author":"S Grauer","year":"1999","unstructured":"Grauer S, Marquis K (1999) Intracerebral administration of metabotropic glutamate receptor agonists disrupts prepulse inhibition of acoustic startle in Sprague\u2013Dawley rats. Psychopharmacology (Berl) 141:405\u2013412","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"17_CR89_17","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nn1014","volume":"6","author":"JR Gray","year":"2003","unstructured":"Gray JR, Chabris CF et al (2003) Neural mechanisms of general fluid intelligence. Nat Neurosci 6(3):316\u2013322","journal-title":"Nat Neurosci"},{"key":"17_CR90_17","doi-asserted-by":"publisher","unstructured":"Griffin MO, Ceballos G et al (2010) Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action. Pharmacol Res. doi: 10.1016\/j.phrs.2010.1010.1004","DOI":"10.1016\/j.phrs.2010.1010.1004"},{"key":"17_CR91_17","doi-asserted-by":"publisher","first-page":"10624","DOI":"10.1523\/JNEUROSCI.0402-10.2010","volume":"30","author":"C Gross","year":"2010","unstructured":"Gross C, Nakamoto M et al (2010) Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome. J Neurosci 30:10624\u201310638","journal-title":"J Neurosci"},{"key":"17_CR92_17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.brainres.2006.02.044","volume":"1084","author":"A Grossman","year":"2006","unstructured":"Grossman A, Elisseou N et al (2006) Hippocampal pyramidal cells in adult Fmr1 knockout mice exhibit an immature-appearing profile of dendritic spines. Brain Res 1084:158\u2013164","journal-title":"Brain Res"},{"key":"17_CR93_17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neuint.2003.12.001","volume":"45","author":"M Gruss","year":"2004","unstructured":"Gruss M, Braun K (2004) Age- and region-specific imbalances of basal amino acids and monoamine metabolism in limbic regions of female Fmr1 knock-out mice. Neurochem Int 45:81\u201388","journal-title":"Neurochem Int"},{"issue":"3","key":"17_CR94_17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1080\/1360786031000101175","volume":"7","author":"VK Gunther","year":"2003","unstructured":"Gunther VK, Schafer P et al (2003) Long-term improvements in cognitive performance through computer-assisted cognitive training: a pilot study in a residential home for older people. Aging Ment Health 7(3):200\u2013206","journal-title":"Aging Ment Health"},{"key":"17_CR95_17","volume-title":"Fragile X syndrome. Diagnosis, treatment, and research","author":"R Hagerman","year":"1991","unstructured":"Hagerman R, Silverman A (1991) Fragile X syndrome. Diagnosis, treatment, and research. Johns Hopkins University Press, Baltimore, MD"},{"issue":"1\u20132","key":"17_CR96_17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/ajmg.1320300138","volume":"30","author":"RJ Hagerman","year":"1988","unstructured":"Hagerman RJ, Murphy MA et al (1988) A controlled trial of stimulant medication in children with the fragile X syndrome. Am J Med Genet 30(1\u20132):377\u2013392","journal-title":"Am J Med Genet"},{"key":"17_CR97_17","first-page":"155","volume":"7","author":"RJ Hagerman","year":"1994","unstructured":"Hagerman RJ, Fulton MJ et al (1994) A survey of fluoxetine therapy in fragile X syndrome. Dev Brain Dysfunct 7:155\u2013164","journal-title":"Dev Brain Dysfunct"},{"issue":"1","key":"17_CR98_17","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1542\/peds.2008-0317","volume":"123","author":"RJ Hagerman","year":"2009","unstructured":"Hagerman RJ, Berry-Kravis E et al (2009) Advances in the treatment of fragile X syndrome. Pediatrics 123(1):378\u2013390","journal-title":"Pediatrics"},{"issue":"1","key":"17_CR99_17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/2040-2392-1-12","volume":"1","author":"RJ Hagerman","year":"2010","unstructured":"Hagerman RJ, Hoem G et al (2010) Fragile X and autism: intertwined at the molecular level leading to targeted treatments. Mol Autism 1(1):12","journal-title":"Mol Autism"},{"key":"17_CR100_17","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1517\/13543784.2010.482926","volume":"19","author":"R Hardeland","year":"2010","unstructured":"Hardeland R (2010) Investigational melatonin receptor agonists. Expert Opin Investig Drugs 19:747\u2013764","journal-title":"Expert Opin Investig Drugs"},{"key":"17_CR101_17","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.neuron.2004.05.003","volume":"42","author":"M Hayashi","year":"2004","unstructured":"Hayashi M, Choi S et al (2004) Altered cortical synaptic morphology and impaired memory consolidation in forebrain- specific dominant-negative PAK transgenic mice. Neuron 42:773\u2013787","journal-title":"Neuron"},{"key":"17_CR102_17","doi-asserted-by":"publisher","first-page":"11489","DOI":"10.1073\/pnas.0705003104","volume":"104","author":"M Hayashi","year":"2007","unstructured":"Hayashi M, Rao B et al (2007) Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice. Proc Natl Acad Sci USA 104:11489\u201311494","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR103_17","doi-asserted-by":"publisher","unstructured":"Hessl D, Berry-Kravis E et al (2008) Prepulse inhibition in fragile X syndrome: Feasibility, reliability, and implications for treatment. Am J Med Genet B Neuropsychiatr Genet. doi: 10.1002\/ajmg.b.30858","DOI":"10.1002\/ajmg.b.30858"},{"key":"17_CR104_17","unstructured":"Hessl D, Maltas S et al (2010) Toward a fragile X behavior rating scale: the aberrant behavior checklist collaborative study [abstract]. 12th International Fragile X Conference; July 21st, Detroit, MI"},{"key":"17_CR105_17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/ajmg.1320410306","volume":"41","author":"V Hinton","year":"1991","unstructured":"Hinton V, Brown W et al (1991) Analysis of neocortex in three males with fragile X syndrome. Am J Med Genet 41:289\u2013294","journal-title":"Am J Med Genet"},{"issue":"2","key":"17_CR106_17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/(SICI)1096-8628(19990312)83:2<140::AID-AJMG11>3.0.CO;2-6","volume":"83","author":"H Hjalgrim","year":"1999","unstructured":"Hjalgrim H, Jacobsen TB et al (1999) Frontal-subcortical hypofunction in the fragile X syndrome [letter]. Am J Med Genet 83(2):140\u2013141","journal-title":"Am J Med Genet"},{"issue":"4","key":"17_CR107_17","doi-asserted-by":"publisher","first-page":"F9","DOI":"10.1111\/j.1467-7687.2009.00848.x","volume":"12","author":"J Holmes","year":"2009","unstructured":"Holmes J, Gathercole SE et al (2009) Adaptive training leads to sustained enhancement of poor working memory in children. Dev Sci 12(4):F9\u201315","journal-title":"Dev Sci"},{"key":"17_CR108_17","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/acp.1589","volume":"24","author":"J Holmes","year":"2010","unstructured":"Holmes J, Gathercole SE et al (2010) Working memory deficits can be overcome: impacts of training and medication on working memory in children with ADHD. Appl Cogn Psychol 24:827\u2013836","journal-title":"Appl Cogn Psychol"},{"key":"17_CR109_17","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.1523\/JNEUROSCI.0995-04.2004","volume":"24","author":"L Hou","year":"2004","unstructured":"Hou L, Klann E (2004) Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J Neurosci 24:6352\u20136361","journal-title":"J Neurosci"},{"key":"17_CR110_17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.neuron.2006.07.005","volume":"51","author":"L Hou","year":"2006","unstructured":"Hou L, Antion M et al (2006) Dynamic translational and proteasomal regulation of Fragile X mental retardation protein controls mGluR-dependent long-term depression. Neuron 51:441\u2013454","journal-title":"Neuron"},{"key":"17_CR111_17","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.288.5469.1254","volume":"288","author":"K Huber","year":"2000","unstructured":"Huber K, Kayser M et al (2000) Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. Science 288:1254\u20131257","journal-title":"Science"},{"key":"17_CR112_17","doi-asserted-by":"publisher","first-page":"7746","DOI":"10.1073\/pnas.122205699","volume":"99","author":"K Huber","year":"2002","unstructured":"Huber K, Gallagher S et al (2002) Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA 99:7746\u20137750","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR113_17","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1006\/exnr.1997.6581","volume":"146","author":"M Ingvar","year":"1997","unstructured":"Ingvar M, Ambros-Ingerson J et al (1997) Enhancement by an ampakine of memory encoding in humans. Exp Neurol 146:553\u2013559","journal-title":"Exp Neurol"},{"key":"17_CR114_17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B","volume":"98","author":"S Irwin","year":"2001","unstructured":"Irwin S, Patel B et al (2001) Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am J Med Genet 98:161\u2013167","journal-title":"Am J Med Genet"},{"key":"17_CR115_17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/ajmg.10500","volume":"111","author":"S Irwin","year":"2002","unstructured":"Irwin S, Idupulapati M et al (2002) Dendritic spine and dendritic field characteristics on layer V pyramidal neurons in the visual cortex of fragile-X knockout mice. Am J Med Genet 111:140\u2013146","journal-title":"Am J Med Genet"},{"issue":"64","key":"17_CR116_17","doi-asserted-by":"publisher","first-page":"64ra61","DOI":"10.1126\/scitranslmed.3001708","volume":"3","author":"S Jacquemont","year":"2011","unstructured":"Jacquemont S, Curie A et al (2011) Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Sci Transl Med 3(64):64ra61","journal-title":"Sci Transl Med"},{"issue":"19","key":"17_CR117_17","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.1073\/pnas.0801268105","volume":"105","author":"SM Jaeggi","year":"2008","unstructured":"Jaeggi SM, Buschkuehl M et al (2008) Improving fluid intelligence with training on working memory. Proc Natl Acad Sci USA 105(19):6829\u20136833","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR118_17","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.neuropharm.2009.01.015","volume":"56","author":"H Jourdi","year":"2009","unstructured":"Jourdi H, Hamo L et al (2009a) BDNF mediates the neuroprotective effects of positive AMPA receptor modulators against MPP+-induced toxicity in cultured hippocampal and mesencephalic slices. Neuropharmacology 56:876\u2013885","journal-title":"Neuropharmacology"},{"issue":"27","key":"17_CR119_17","doi-asserted-by":"publisher","first-page":"8688","DOI":"10.1523\/JNEUROSCI.6078-08.2009","volume":"29","author":"H Jourdi","year":"2009","unstructured":"Jourdi H, Hsu YT et al (2009b) Positive AMPA receptor modulation rapidly stimulates BDNF release and increases dendritic mRNA translation. J Neurosci 29(27):8688\u20138697","journal-title":"J Neurosci"},{"issue":"4","key":"17_CR120_17","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3758\/BF03196323","volume":"9","author":"MJ Kane","year":"2002","unstructured":"Kane MJ, Engle RW (2002) The role of prefrontal cortex in working-memory capacity, executive attention, and general fluid intelligence: an individual-differences perspective. Psychon Bull Rev 9(4):637\u2013671","journal-title":"Psychon Bull Rev"},{"issue":"1","key":"17_CR121_17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1037\/0033-2909.131.1.66","volume":"131","author":"MJ Kane","year":"2005","unstructured":"Kane MJ, Hambrick DZ et al (2005) Working memory capacity and fluid intelligence are strongly related constructs: comment on Ackerman, Beier, and Boyle (2005). Psychol Bull 131(1):66\u201371, author reply 72\u201365","journal-title":"Psychol Bull"},{"issue":"suppl 3","key":"17_CR122_17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1528-1167.2010.02625.x","volume":"51","author":"L Karr","year":"2010","unstructured":"Karr L, Pan Y et al (2010) CB1 receptor antagonism impairs the induction of epileptiform activity by group I metabotropic glutamate receptor activation. Epilepsia 51(suppl 3):121\u2013125","journal-title":"Epilepsia"},{"issue":"3","key":"17_CR123_17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.cell.2008.10.017","volume":"135","author":"RJ Kelleher 3rd","year":"2008","unstructured":"Kelleher RJ 3rd, Bear MF (2008) The autistic neuron: troubled translation? Cell 135(3):401\u2013406","journal-title":"Cell"},{"issue":"9","key":"17_CR124_17","doi-asserted-by":"publisher","first-page":"e931","DOI":"10.1371\/journal.pone.0000931","volume":"2","author":"DJ Kelley","year":"2007","unstructured":"Kelley DJ, Davidson RJ et al (2007) The cyclic AMP cascade is altered in the fragile X nervous system. PLoS One 2(9):e931","journal-title":"PLoS One"},{"issue":"11","key":"17_CR125_17","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1073\/pnas.0800257105","volume":"105","author":"SH Kim","year":"2008","unstructured":"Kim SH, Markham JA et al (2008) Aberrant early-phase ERK inactivation impedes neuronal function in fragile X syndrome. Proc Natl Acad Sci USA 105(11):4429\u20134434","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR126_17","volume-title":"The overflowing brain: information overload and the limits of working memory","author":"T Klingberg","year":"2009","unstructured":"Klingberg T (2009) The overflowing brain: information overload and the limits of working memory. Oxford University Press, New York, NY"},{"issue":"7","key":"17_CR127_17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.tics.2010.05.002","volume":"14","author":"T Klingberg","year":"2010","unstructured":"Klingberg T (2010) Training and plasticity of working memory. Trends Cogn Sci 14(7):317\u2013324","journal-title":"Trends Cogn Sci"},{"issue":"6","key":"17_CR128_17","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1076\/jcen.24.6.781.8395","volume":"24","author":"T Klingberg","year":"2002","unstructured":"Klingberg T, Forssberg H et al (2002) Training of working memory in children with ADHD. J Clin Exp Neuropsychol 24(6):781\u2013791","journal-title":"J Clin Exp Neuropsychol"},{"issue":"2","key":"17_CR129_17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/00004583-200502000-00010","volume":"44","author":"T Klingberg","year":"2005","unstructured":"Klingberg T, Fernell E et al (2005) Computerized training of working memory in children with ADHD\u2013a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 44(2):177\u2013186","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"17_CR130_17","first-page":"S108","volume":"66","author":"A Knox","year":"2009","unstructured":"Knox A, Berry-Kravis E (2009) Feasibility and reproducibility of the Tests of Attentional Performance for Children (KiTAP) in Fragile X Syndrome (FXS). Ann Neurol 66:S108","journal-title":"Ann Neurol"},{"key":"17_CR131_17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.neuron.2005.07.005","volume":"47","author":"S Koekkoek","year":"2005","unstructured":"Koekkoek S, Yamaguchi K et al (2005) Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome. Neuron 47:339\u2013352","journal-title":"Neuron"},{"key":"17_CR132_17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/(SICI)1096-8628(19960809)64:2<241::AID-AJMG1>3.0.CO;2-X","volume":"64","author":"R Kooy","year":"1996","unstructured":"Kooy R, D'Hooge R et al (1996) Transgenic mouse model for the fragile X syndrome. Am J Med Genet 64:241\u2013245","journal-title":"Am J Med Genet"},{"key":"17_CR133_17","unstructured":"Kooy F, Heulens I et al (2010) The GABAA receptor as a potential target for therapy of the fragile X syndrome [abstract]. NFXF 12th International FX Conference, Detroit, MI"},{"key":"17_CR134_17","doi-asserted-by":"publisher","unstructured":"Kramar EA, Chen LY et al (2010) BDNF upregulation rescues synaptic plasticity in middle-aged ovariectomized rats. Neurobiol Aging. doi: 10.1016\/j.neurobiolaging.2010.1006.1008","DOI":"10.1016\/j.neurobiolaging.2010.1006.1008"},{"key":"17_CR135_17","doi-asserted-by":"publisher","first-page":"5151","DOI":"10.1523\/JNEUROSCI.0800-04.2004","volume":"24","author":"E Kram\u00e1r","year":"2004","unstructured":"Kram\u00e1r E, Lin B et al (2004) A novel mechanism for the facilitation of theta-induced long-term potentiation by brain-derived neurotrophic factor. J Neurosci 24:5151\u20135161","journal-title":"J Neurosci"},{"issue":"5","key":"17_CR136_17","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1037\/0894-4105.21.5.569","volume":"21","author":"WS Kremen","year":"2007","unstructured":"Kremen WS, Jacobsen KC et al (2007) Genetics of verbal working memory processes: a twin study of middle-aged men. Neuropsychology 21(5):569\u2013580","journal-title":"Neuropsychology"},{"issue":"5","key":"17_CR137_17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/sleep\/33.5.679","volume":"33","author":"R Kronk","year":"2010","unstructured":"Kronk R, Bishop EE et al (2010) Prevalence, nature, and correlates of sleep problems among children with fragile X syndrome based on a large scale parent survey. Sleep 33(5):679\u2013687","journal-title":"Sleep"},{"issue":"7","key":"17_CR138_17","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1176\/appi.ajp.158.7.1040","volume":"158","author":"H Kwon","year":"2001","unstructured":"Kwon H, Menon V et al (2001) Functional neuroanatomy of visuospatial working memory in fragile X syndrome: relation to behavioral and molecular measures. Am J Psychiatry 158(7):1040\u20131051","journal-title":"Am J Psychiatry"},{"key":"17_CR139_17","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0160-2896(05)80012-1","volume":"14","author":"P Kyllonen","year":"1990","unstructured":"Kyllonen P, Christal R (1990) Reasoning ability is (little more than) working memory capacity?! Intelligence 14:389\u2013433","journal-title":"Intelligence"},{"issue":"2","key":"17_CR140_17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/09297040802112564","volume":"15","author":"S Lanfranchi","year":"2009","unstructured":"Lanfranchi S, Cornoldi C et al (2009) Working memory in individuals with fragile X syndrome. Child Neuropsychol 15(2):105\u2013119","journal-title":"Child Neuropsychol"},{"key":"17_CR141_17","doi-asserted-by":"publisher","first-page":"9460","DOI":"10.1523\/JNEUROSCI.2638-05.2005","volume":"25","author":"J Larson","year":"2005","unstructured":"Larson J, Jessen R et al (2005) Age-dependent and selective impairment of long-term potentiation in the anterior piriform cortex of mice lacking the fragile X mental retardation protein. J Neurosci 25:9460\u20139469","journal-title":"J Neurosci"},{"key":"17_CR142_17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.nlm.2008.01.002","volume":"90","author":"J Larson","year":"2008","unstructured":"Larson J, Kim D et al (2008) Olfactory discrimination learning in mice lacking the fragile X mental retardation protein. Neurobiol Learn Mem 90:90\u2013102","journal-title":"Neurobiol Learn Mem"},{"key":"17_CR143_17","first-page":"13","volume":"116","author":"J Lauterborn","year":"2004","unstructured":"Lauterborn J, Gall C (2004) Ampakines increase hippocampal and neocortical BDNF expression in a mouse model of Fragile X in vitro. Soc Neurosci Abst 116:13","journal-title":"Soc Neurosci Abst"},{"key":"17_CR144_17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1523\/JNEUROSCI.20-01-00008.2000","volume":"20","author":"JC Lauterborn","year":"2000","unstructured":"Lauterborn JC, Lynch G et al (2000) Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons. J Neurosci 20:8\u201321","journal-title":"J Neurosci"},{"key":"17_CR145_17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1124\/jpet.103.053694","volume":"307","author":"J Lauterborn","year":"2003","unstructured":"Lauterborn J, Troung G et al (2003) Chronic elevation of brain-derived neurotrophic factor by ampkaines. J Pharmacol Exp Ther 307:297\u2013305","journal-title":"J Pharmacol Exp Ther"},{"key":"17_CR146_17","doi-asserted-by":"publisher","first-page":"10685","DOI":"10.1523\/JNEUROSCI.2624-07.2007","volume":"27","author":"J Lauterborn","year":"2007","unstructured":"Lauterborn J, Rex C et al (2007) Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome. J Neurosci 27:10685\u201310694","journal-title":"J Neurosci"},{"key":"17_CR147_17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.neuroscience.2008.12.018","volume":"159","author":"J Lauterborn","year":"2009","unstructured":"Lauterborn J, Pineda E et al (2009) Ampakines cause sustained increases in brain-derived neurotrophic factor signaling at excitatory synapses without changes in AMPA receptor subunit expression. Neuroscience 159:283\u2013295","journal-title":"Neuroscience"},{"key":"17_CR148_17","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1242\/dev.00792","volume":"130","author":"A Lee","year":"2003","unstructured":"Lee A, Li W et al (2003) Control of dendritic development by the Drosophila fragile X-related gene involves the small GTPase Rac1. Dev Dis 130:5543\u20135552","journal-title":"Dev Dis"},{"key":"17_CR149_17","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0028-3908(01)00006-5","volume":"40","author":"B Legutko","year":"2001","unstructured":"Legutko B, Li X et al (2001) Regulation of BDNF expression in primary neuron culture by LY392098, a novel AMPA receptor potentiator. Neuropharmacology 40:1019\u20131027","journal-title":"Neuropharmacology"},{"key":"17_CR150_17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1006\/mcne.2001.1085","volume":"19","author":"J Li","year":"2002","unstructured":"Li J, Pelletier MR et al (2002) Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency. Mol Cell Neurosci 19:138\u2013151","journal-title":"Mol Cell Neurosci"},{"key":"17_CR151_17","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1017\/S1461145710000520","volume":"14","author":"ZH Liu","year":"2010","unstructured":"Liu ZH, Chuang DM et al (2010) Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome.\". Int J Neuropsychopharmacol 14:618\u2013630","journal-title":"Int J Neuropsychopharmacol"},{"key":"17_CR152_17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.nbd.2010.10.018","volume":"41","author":"V Louhivuori","year":"2011","unstructured":"Louhivuori V, Vicario A et al (2011) BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse. Neurobiol Dis 41:469\u2013480","journal-title":"Neurobiol Dis"},{"issue":"1","key":"17_CR153_17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1162\/jocn.1992.4.1.58","volume":"4","author":"M Luciana","year":"1992","unstructured":"Luciana M, Depue R et al (1992) Facilitation of working memory in humans by a D2 dopamine receptor agonist. J Cogn Neurosci 4(1):58\u201368","journal-title":"J Cogn Neurosci"},{"issue":"4","key":"17_CR154_17","doi-asserted-by":"publisher","first-page":"e1000898","DOI":"10.1371\/journal.pgen.1000898","volume":"6","author":"Y Luo","year":"2010","unstructured":"Luo Y, Shan G et al (2010) Fragile x mental retardation protein regulates proliferation and differentiation of adult neural stem\/progenitor cells. PLoS Genet 6(4):e1000898","journal-title":"PLoS Genet"},{"issue":"10","key":"17_CR155_17","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.tins.2006.07.007","volume":"29","author":"G Lynch","year":"2006","unstructured":"Lynch G, Gall CM (2006) Ampakines and the threefold path to cognitive enhancement. Trends Neurosci 29(10):554\u2013562","journal-title":"Trends Neurosci"},{"issue":"16","key":"17_CR156_17","doi-asserted-by":"publisher","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","volume":"27","author":"G Lynch","year":"2007","unstructured":"Lynch G, Kramar EA et al (2007) Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease. J Neurosci 27(16):4424\u20134434","journal-title":"J Neurosci"},{"issue":"15","key":"17_CR157_17","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1523\/JNEUROSCI.5966-09.2010","volume":"30","author":"I Maezawa","year":"2010","unstructured":"Maezawa I, Jin LW (2010) Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J Neurosci 30(15):5346\u20135356","journal-title":"J Neurosci"},{"issue":"4","key":"17_CR158_17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/01.chi.0000153228.72591.73","volume":"44","author":"R Martinussen","year":"2005","unstructured":"Martinussen R, Hayden J et al (2005) A meta-analysis of working memory impairments in children with attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 44(4):377\u2013384","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"17_CR159_17","first-page":"170","volume-title":"Cognitive and behavioral abnormalities of pediatric diseases","author":"AM Mastergeorge","year":"2010","unstructured":"Mastergeorge AM, Au J et al (2010) Fragile X: a family of disorders. In: Nass R, Frank Y (eds) Cognitive and behavioral abnormalities of pediatric diseases. Oxford University Press, New York, pp 170\u2013187"},{"issue":"6","key":"17_CR160_17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1023\/A:1026000111467","volume":"28","author":"MMM Mazzocco","year":"1998","unstructured":"Mazzocco MMM, Baumgardner T et al (1998) Social functioning among girls with fragile X or Turner syndrome and their sisters. J Autism Dev Disord 28(6):509\u2013517","journal-title":"J Autism Dev Disord"},{"key":"17_CR161_17","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.neuron.2005.01.038","volume":"45","author":"S McBride","year":"2005","unstructured":"McBride S, Choi C et al (2005) Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a model of fragile X syndrome. Neuron 45:753\u2013764","journal-title":"Neuron"},{"issue":"1","key":"17_CR162_17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00221-006-0849-0","volume":"180","author":"MN McDonnell","year":"2007","unstructured":"McDonnell MN, Orekhov Y et al (2007) Suppression of LTP-like plasticity in human motor cortex by the GABAB receptor agonist baclofen. Exp Brain Res 180(1):181\u2013186","journal-title":"Exp Brain Res"},{"key":"17_CR163_17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1601-183X.2007.00330.x","volume":"7","author":"H McFarlane","year":"2008","unstructured":"McFarlane H, Kusek G et al (2008) Autism-like behavioral phenotypes in BTBR T+tf\/J mice. Genes Brain Behav 7:152\u2013163","journal-title":"Genes Brain Behav"},{"key":"17_CR164_17","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.1158\/0008-5472.CAN-08-4285","volume":"69","author":"D McMillin","year":"2009","unstructured":"McMillin D, Ooi M et al (2009) Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor NVP-BEZ235. Cancer Res 69:5835\u20135842","journal-title":"Cancer Res"},{"issue":"5915","key":"17_CR165_17","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1126\/science.1166102","volume":"323","author":"F McNab","year":"2009","unstructured":"McNab F, Varrone A et al (2009) Changes in cortical dopamine D1 receptor binding associated with cognitive training. Science 323(5915):800\u2013802","journal-title":"Science"},{"key":"17_CR166_17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1037\/0735-7044.122.2.293","volume":"122","author":"C McNaughton","year":"2008","unstructured":"McNaughton C, Moon J et al (2008) Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome. Behav Neurosci 122:293\u2013300","journal-title":"Behav Neurosci"},{"key":"17_CR167_17","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2007.04.028","volume":"54","author":"R Meredith","year":"2007","unstructured":"Meredith R, Holmgren C et al (2007) Increased threshold for spike-timing-dependent plasticity is caused by unreliable calcium signaling in mice lacking fragile X gene FMR1. Neuron 54:627\u2013638","journal-title":"Neuron"},{"key":"17_CR168_17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.nbd.2010.08.026","volume":"41","author":"R Meredith","year":"2011","unstructured":"Meredith R, de Jong R et al (2011) Functional rescue of excitatory synaptic transmission in the developing hippocampus in Fmr1-KO mouse. Neurobiol Dis 41:104\u2013110","journal-title":"Neurobiol Dis"},{"issue":"2","key":"17_CR169_17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1037\/h0043158","volume":"63","author":"GA Miller","year":"1956","unstructured":"Miller GA (1956) The magical number seven plus or minus two: some limits on our capacity for processing information. Psychol Rev 63(2):81\u201397","journal-title":"Psychol Rev"},{"key":"17_CR170_17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/(SICI)1096-8628(19990402)83:4<268::AID-AJMG7>3.0.CO;2-K","volume":"83","author":"L Miller","year":"1999","unstructured":"Miller L, McIntosh D et al (1999) Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. Am J Med Genet 83:268\u2013279","journal-title":"Am J Med Genet"},{"issue":"2","key":"17_CR171_17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.neuropharm.2008.09.017","volume":"56","author":"WW Min","year":"2009","unstructured":"Min WW, Yuskaitis CJ et al (2009) Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential. Neuropharmacology 56(2):463\u2013472","journal-title":"Neuropharmacology"},{"key":"17_CR172_17","doi-asserted-by":"publisher","first-page":"e9706","DOI":"10.1371\/journal.pone.0009706","volume":"5","author":"M Mines","year":"2010","unstructured":"Mines M, Yuskaitis C et al (2010) GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile x syndrome and autism. PLoS One 5:e9706","journal-title":"PLoS One"},{"key":"17_CR173_17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/hipo.10005","volume":"12","author":"YS Mineur","year":"2002","unstructured":"Mineur YS, Sluyter F et al (2002) Behavorial and neuroanatomical characterization of the Fmr1 knockout mouse. Hippocampus 12:39\u201346","journal-title":"Hippocampus"},{"key":"17_CR174_17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bbr.2005.11.004","volume":"168","author":"Y Mineur","year":"2006","unstructured":"Mineur Y, Huynh L et al (2006) Social behavior deficits in the Fmr1 mutant mouse. Behav Brain Res 168:172\u2013175","journal-title":"Behav Brain Res"},{"key":"17_CR175_17","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nrn2738","volume":"10","author":"L Minichiello","year":"2009","unstructured":"Minichiello L (2009) TrkB signalling pathways in LTP and learning. Nat Rev Neurosci 10:850\u2013860","journal-title":"Nat Rev Neurosci"},{"key":"17_CR176_17","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.1523\/JNEUROSCI.0937-07.2007","volume":"27","author":"R Muddashetty","year":"2007","unstructured":"Muddashetty R, Keli\u0107 S et al (2007) Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome. J Neurosci 27:5338\u20135348","journal-title":"J Neurosci"},{"key":"17_CR177_17","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1523\/JNEUROSCI.18-07-02720.1998","volume":"18","author":"D M\u00fcller","year":"1998","unstructured":"M\u00fcller D, von Cramon Y et al (1998) D1- versus D2-receptor modulation of visuospatial working memory in humans. J Neurosci 18:2720\u20132728","journal-title":"J Neurosci"},{"issue":"9","key":"17_CR178_17","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/S0028-3932(00)00036-1","volume":"38","author":"F Munir","year":"2000","unstructured":"Munir F, Cornish KM et al (2000) A neuropsychological profile of attention deficits in young males with fragile X syndrome. Neuropsychologia 38(9):1261\u20131270","journal-title":"Neuropsychologia"},{"key":"17_CR179_17","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/j.1528-1157.1999.tb00824.x","volume":"40","author":"S Musumeci","year":"1999","unstructured":"Musumeci S, Hagerman R et al (1999) Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia 40:1092\u20131099","journal-title":"Epilepsia"},{"key":"17_CR180_17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.expneurol.2006.08.007","volume":"203","author":"S Musumeci","year":"2007","unstructured":"Musumeci S, Calabrese G et al (2007) Audiogenic seizure susceptibility is reduced in fragile X knockout mice after introduction of FMR1 transgenes. Exp Neurol 203:233\u2013240","journal-title":"Exp Neurol"},{"key":"17_CR181_17","doi-asserted-by":"publisher","first-page":"15537","DOI":"10.1073\/pnas.0707484104","volume":"104","author":"M Nakamoto","year":"2007","unstructured":"Nakamoto M, Nalavadi V et al (2007) Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors. Proc Natl Acad Sci USA 104:15537\u201315542","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR1_17","unstructured":"National Institute of Child Health and Human Development, Office of Rare Disease Research, National Institute of Mental Health, and National Institute of Neurological Disorders and Stroke (2009) Outcome measures for clinical trials in children with Fragile X syndrome \u2013 meeting summary. Bethesda Marriott Pooks Hill, Bethesda, MD. http:\/\/rarediseases.info.nih.gov\/ScientificConferences.aspx?PageID=5&ID=989"},{"issue":"4","key":"17_CR182_17","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/0305498930190407","volume":"19","author":"M Niaz","year":"1993","unstructured":"Niaz M, Logie RH (1993) Working memory, mental capacity and science education: towards an understanding of the 'working memory overload hypothesis'. Oxf Rev Educ 19(4):511\u2013525","journal-title":"Oxf Rev Educ"},{"key":"17_CR183_17","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1152\/jn.01316.2005","volume":"95","author":"E Nosyreva","year":"2006","unstructured":"Nosyreva E, Huber K (2006) Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome. J Neurophysiol 95:3291\u20133295","journal-title":"J Neurophysiol"},{"issue":"1","key":"17_CR184_17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nn1165","volume":"7","author":"PJ Olesen","year":"2004","unstructured":"Olesen PJ, Westerberg H et al (2004) Increased prefrontal and parietal activity after training of working memory. Nat Neurosci 7(1):75\u201379","journal-title":"Nat Neurosci"},{"key":"17_CR185_17","doi-asserted-by":"publisher","first-page":"9929","DOI":"10.1523\/JNEUROSCI.1714-10.2010","volume":"30","author":"J Olmos-Serrano","year":"2010","unstructured":"Olmos-Serrano J, Paluszkiewicz S et al (2010) Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome. J Neurosci 30:9929\u20139938","journal-title":"J Neurosci"},{"issue":"4","key":"17_CR186_17","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S1044-7431(03)00095-2","volume":"23","author":"R Owen","year":"2003","unstructured":"Owen R, Gordon-Weeks PR (2003) Inhibition of glycogen synthase kinase 3beta in sensory neurons in culture alters filopodia dynamics and microtubule distribution in growth cones. Mol Cell Neurosci 23(4):626\u2013637","journal-title":"Mol Cell Neurosci"},{"key":"17_CR187_17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1124\/mol.109.056127","volume":"76","author":"L Pacey","year":"2009","unstructured":"Pacey L, Heximer S et al (2009) Increased GABA(B) receptor-mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures. Mol Pharmacol 76:18\u201324","journal-title":"Mol Pharmacol"},{"issue":"1","key":"17_CR188_17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0306-4522(99)00285-7","volume":"94","author":"W Paradee","year":"1999","unstructured":"Paradee W, Melikian HE et al (1999) Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function. Neuroscience 94(1):185\u2013192","journal-title":"Neuroscience"},{"key":"17_CR189_17","doi-asserted-by":"crossref","unstructured":"Paribello C (2010) Open label add on treatment trial of minocycline in patients with fragile X syndrome [abstract]. FRAXA investigators meeting Durham, NH","DOI":"10.1186\/1471-2377-10-91"},{"key":"17_CR190_17","unstructured":"Paylor R (2008) Pharmacological modification of behavioral responses in the fragile X mouse model [abstract]. 11th International Fragile X Conference St. Louis, Missouri"},{"key":"17_CR191_17","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/hmg\/9.8.1145","volume":"9","author":"A Peier","year":"2000","unstructured":"Peier A, McIlwain K et al (2000) (Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features. Hum Mol Genet 9:1145\u20131159","journal-title":"Hum Mol Genet"},{"issue":"7304","key":"17_CR192_17","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature09146","volume":"466","author":"D Pinto","year":"2010","unstructured":"Pinto D, Pagnamenta AT et al (2010) Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466(7304):368\u2013372","journal-title":"Nature"},{"issue":"3","key":"17_CR193_17","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.neuroscience.2005.06.081","volume":"135","author":"M Qin","year":"2005","unstructured":"Qin M, Kang J et al (2005) A null mutation for Fmr1 in female mice: effects on regional cerebral metabolic rate for glucose and relationship to behavior. Neuroscience 135(3):999\u20131009","journal-title":"Neuroscience"},{"key":"17_CR194_17","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1093\/cercor\/bhn163","volume":"19","author":"L Qiu","year":"2009","unstructured":"Qiu L, Lu T et al (2009) Limbic epileptogenesis in a mouse model of fragile X syndrome. Cereb Cortex 19:1504\u20131514","journal-title":"Cereb Cortex"},{"issue":"1","key":"17_CR195_17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ajmg.a.33183","volume":"152A","author":"KA Rauen","year":"2010","unstructured":"Rauen KA, Schoyer L et al (2010) Proceedings from the 2009 genetic syndromes of the Ras\/MAPK pathway: From bedside to bench and back. Am J Med Genet A 152A(1):4\u201324","journal-title":"Am J Med Genet A"},{"key":"17_CR196_17","doi-asserted-by":"publisher","first-page":"11557","DOI":"10.1073\/pnas.0504984102","volume":"102","author":"L Restivo","year":"2005","unstructured":"Restivo L, Ferrari F et al (2005) Enriched environment promotes behavioral and morphological recovery in a mouse model for the fragile X syndrome. Proc Natl Acad Sci USA 102:11557\u201311562","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"17_CR197_17","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1152\/jn.00336.2006","volume":"96","author":"CS Rex","year":"2006","unstructured":"Rex CS, Lauterborn JC et al (2006) Restoration of long-term potentiation in middle-aged hippocampus after induction of brain-derived neurotrophic factor. J Neurophysiol 96(2):677\u2013685","journal-title":"J Neurophysiol"},{"key":"17_CR198_17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1083\/jcb.200901084","volume":"186","author":"C Rex","year":"2009","unstructured":"Rex C, Chen L et al (2009) Different Rho GTPase-dependent signaling pathways initiate sequential steps in the consolidation of long-term potentiation. J Cell Biol 186:85\u201397","journal-title":"J Cell Biol"},{"issue":"1","key":"17_CR199_17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1017\/S0012162299000122","volume":"41","author":"AL Richdale","year":"1999","unstructured":"Richdale AL (1999) Sleep problems in autism: prevalence, cause, and intervention. Dev Med Child Neurol 41(1):60\u201366","journal-title":"Dev Med Child Neurol"},{"key":"17_CR200_17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/1366825031000147076","volume":"28","author":"A Richdale","year":"2003","unstructured":"Richdale A (2003) A descriptive analysis of sleep behaviour in children with fragile X. J Intellect Dev Disabil 28:135\u2013144","journal-title":"J Intellect Dev Disabil"},{"issue":"2","key":"17_CR201_17","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1600-079X.2008.00653.x","volume":"46","author":"Y Romero-Zerbo","year":"2009","unstructured":"Romero-Zerbo Y, Decara J et al (2009) Protective effects of melatonin against oxidative stress in Fmr1 knockout mice: a therapeutic research model for the fragile X syndrome. J Pineal Res 46(2):224\u2013234","journal-title":"J Pineal Res"},{"key":"17_CR202_17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF00687814","volume":"67","author":"R Rudelli","year":"1985","unstructured":"Rudelli R, Brown W et al (1985) Adult fragile X Syndrome. Clinico-neuropathologic findings. Acta Neuropathol 67:289\u2013295","journal-title":"Acta Neuropathol"},{"issue":"1","key":"17_CR203_17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neulet.2007.12.039","volume":"433","author":"N Rueda","year":"2008","unstructured":"Rueda N, Florez J et al (2008) Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome. Neurosci Lett 433(1):22\u201327","journal-title":"Neurosci Lett"},{"key":"17_CR204_17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1053\/seiz.2000.0492","volume":"10","author":"M Sabaratnam","year":"2001","unstructured":"Sabaratnam M, Vroegop P et al (2001) Epilepsy and EEG findings in 18 males with fragile X syndrome. Seizure 10:60\u201363","journal-title":"Seizure"},{"key":"17_CR206_17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.neulet.2006.11.062","volume":"412","author":"L Selby","year":"2007","unstructured":"Selby L, Zhang C et al (2007) Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein. Neurosci Lett 412:227\u2013232","journal-title":"Neurosci Lett"},{"key":"17_CR207_17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1471-4159.2009.06314.x","volume":"111","author":"Y Shang","year":"2009","unstructured":"Shang Y, Wang H et al (2009) Fragile X mental retardation protein is required for chemically-induced long-term potentiation of the hippocampus in adult mice. J Neurochem 111:635\u2013646","journal-title":"J Neurochem"},{"key":"17_CR208_17","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1523\/JNEUROSCI.3696-09.2010","volume":"30","author":"A Sharma","year":"2010","unstructured":"Sharma A, Hoeffer C et al (2010) Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci 30:694\u2013702","journal-title":"J Neurosci"},{"key":"17_CR209_17","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/npp.2009.201","volume":"35","author":"J Silverman","year":"2010","unstructured":"Silverman J, Tolu S et al (2010) Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology 35:976\u2013989","journal-title":"Neuropsychopharmacology"},{"key":"17_CR210_17","doi-asserted-by":"publisher","first-page":"4906","DOI":"10.1073\/pnas.0811228106","volume":"106","author":"D Simmons","year":"2009","unstructured":"Simmons D, Rex C et al (2009) Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice. Proc Natl Acad Sci USA 106:4906\u20134911","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR211_17","doi-asserted-by":"publisher","unstructured":"Singhal NK, Srivastava G et al (2010) Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson's disease phenotype in the mouse. J Pineal Res. doi: 10.1111\/j.1600-1079X.2010.00819.x","DOI":"10.1111\/j.1600-1079X.2010.00819.x"},{"key":"17_CR212_17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0166-4328(01)00431-4","volume":"130","author":"M Solanto","year":"2002","unstructured":"Solanto M (2002) Dopamine dysfunction in AD\/HD: integrating clinical and basic neuroscience research. Behav Brain Res 130:65\u201371","journal-title":"Behav Brain Res"},{"key":"17_CR213_17","volume-title":"Psychology down the ages","author":"C Spearman","year":"1927","unstructured":"Spearman C (1927) Psychology down the ages. Macmillan, London"},{"key":"17_CR214_17","doi-asserted-by":"publisher","first-page":"11158","DOI":"10.1073\/pnas.91.23.11158","volume":"91","author":"U Staubli","year":"1994","unstructured":"Staubli U, Perez Y et al (1994a) Centrally active modulators of glutamate (AMPA) receptors facilitate the induction of LTP in vivo. Proc Natl Acad Sci USA 91:11158\u201311162","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR215_17","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1073\/pnas.91.2.777","volume":"91","author":"U Staubli","year":"1994","unstructured":"Staubli U, Rogers G et al (1994b) Facilitation of glutamate receptors enhances memory. Proc Natl Acad Sci USA 91:777\u2013781","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR216_17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0160-2896(01)00100-3","volume":"20","author":"H Su\u00df","year":"2002","unstructured":"Su\u00df H, Oberauer K et al (2002) Working-memory capacity explains reasoning ability \u2013 and a little bit more. Intelligence 20:261\u2013288","journal-title":"Intelligence"},{"key":"17_CR217_17","doi-asserted-by":"publisher","first-page":"11591","DOI":"10.1073\/pnas.1002262107","volume":"107","author":"A Suvrathan","year":"2010","unstructured":"Suvrathan A, Hoeffer C et al (2010) Characterization and reversal of synaptic defects in the amygdala in a mouse model of fragile X syndrome. Proc Natl Acad Sci USA 107:11591\u201311596","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"17_CR218_17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1006\/jecp.2000.2587","volume":"79","author":"HL Swanson","year":"2001","unstructured":"Swanson HL, Sachse-Lee C (2001a) Mathematical problem solving and working memory in children with learning disabilities: both executive and phonological processes are important. J Exp Child Psychol 79(3):294\u2013321","journal-title":"J Exp Child Psychol"},{"issue":"3","key":"17_CR219_17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/002221940103400305","volume":"34","author":"HL Swanson","year":"2001","unstructured":"Swanson HL, Sachse-Lee C (2001b) A subgroup analysis of working memory in children with reading disabilities: domain-general or domain-specific deficiency? J Learn Disabil 34(3):249\u2013263","journal-title":"J Learn Disabil"},{"issue":"7","key":"17_CR220_17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ajmg.a.32268","volume":"146","author":"MG Torrioli","year":"2008","unstructured":"Torrioli MG, Vernacotola S et al (2008) A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys. Am J Med Genet A 146(7):803\u2013812","journal-title":"Am J Med Genet A"},{"key":"17_CR221_17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1468-3148.1998.tb00060.x","volume":"11","author":"J Turk","year":"1998","unstructured":"Turk J (1998) Fragile X syndrome and attentional deficits. J Appl Res Intellect Disabil 11:175\u2013191","journal-title":"J Appl Res Intellect Disabil"},{"key":"17_CR222_17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jns.2006.03.018","volume":"247","author":"J Ure","year":"2006","unstructured":"Ure J, Baudry M et al (2006) Metabotropic glutamate receptors and epilepsy. J Neurol Sci 247:109","journal-title":"J Neurol Sci"},{"issue":"5","key":"17_CR223_17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1352\/1944-7558-115.5.433","volume":"115","author":"A Utari","year":"2010","unstructured":"Utari A, Chonchaiya W et al (2010) Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures. Am J Intellect Dev Disabil 115(5):433\u2013443","journal-title":"Am J Intellect Dev Disabil"},{"key":"17_CR224_17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0079-6123(04)47022-8","volume":"147","author":"EJ Galen van","year":"2005","unstructured":"van Galen EJ, Ramakers GJ (2005) Rho proteins, mental retardation and the neurobiological basis of intelligence. Prog Brain Res 147:295\u2013317","journal-title":"Prog Brain Res"},{"issue":"8","key":"17_CR225_17","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/j.1651-2227.2003.tb00627.x","volume":"92","author":"I van't Hooft","year":"2003","unstructured":"van't Hooft I, Andersson K et al (2003) Attention and memory training in children with acquired brain injuries. Acta Paediatr 92(8):935\u2013940","journal-title":"Acta Paediatr"},{"key":"17_CR226_17","volume-title":"Rescue of fragile X syndrome metabolic and behavioral phenotypes by lithium [abstract]","author":"DV Venkitaramani","year":"2010","unstructured":"Venkitaramani DV, Aldridge GM et al (2010) Rescue of fragile X syndrome metabolic and behavioral phenotypes by lithium [abstract]. Society for Neuroscience, San Diego, CA, Abstr #: 757.12"},{"key":"17_CR227_17","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/00008877-200409000-00018","volume":"15","author":"R Ventura","year":"2004","unstructured":"Ventura R, Pascucci T et al (2004) Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex. Behav Pharmacol 15:433\u2013442","journal-title":"Behav Pharmacol"},{"key":"17_CR228_17","doi-asserted-by":"publisher","first-page":"11624","DOI":"10.1523\/JNEUROSCI.2266-07.2007","volume":"27","author":"L Volk","year":"2007","unstructured":"Volk L, Pfeiffer B et al (2007) Multiple Gq-coupled receptors converge on a common protein synthesis-dependent long-term depression that is affected in fragile X syndrome mental retardation. J Neurosci 27:11624\u201311634","journal-title":"J Neurosci"},{"key":"17_CR229_17","unstructured":"Vollrath B, Duron S et al (2010) Developing inhibitors of p21-activated kinase (PAK) for the treatment of Fragile X mental retardation. Soc Neurosci Abst 757.2"},{"key":"17_CR230_17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1254\/jphs.09R02CR","volume":"110","author":"A Wada","year":"2009","unstructured":"Wada A (2009) Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades. J Pharmacol Sci 110:14\u201328","journal-title":"J Pharmacol Sci"},{"key":"17_CR231_17","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.neuron.2008.06.027","volume":"59","author":"H Wang","year":"2008","unstructured":"Wang H, Wu L et al (2008a) FMRP acts as a key messenger for dopamine modulation in the forebrain. Neuron 59:634\u2013647","journal-title":"Neuron"},{"issue":"17","key":"17_CR232_17","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1523\/JNEUROSCI.0646-08.2008","volume":"28","author":"H Wang","year":"2008","unstructured":"Wang H, Wu LJ et al (2008b) Roles of calcium-stimulated adenylyl cyclase and calmodulin-dependent protein kinase IV in the regulation of FMRP by group I metabotropic glutamate receptors. J Neurosci 28(17):4385\u20134397","journal-title":"J Neurosci"},{"key":"17_CR233_17","doi-asserted-by":"publisher","first-page":"21888","DOI":"10.1074\/jbc.M110.116293","volume":"285","author":"H Wang","year":"2010","unstructured":"Wang H, Kim S et al (2010a) Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalization. J Biol Chem 285:21888\u201321901","journal-title":"J Biol Chem"},{"issue":"3","key":"17_CR234_17","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.nurt.2010.05.005","volume":"7","author":"LW Wang","year":"2010","unstructured":"Wang LW, Berry-Kravis E et al (2010b) Fragile X: leading the way for targeted treatments in autism. Neurotherapeutics 7(3):264\u2013274","journal-title":"Neurotherapeutics"},{"key":"17_CR235_17","unstructured":"Wang L, Berry-Kravis E et al (in press) Arbaclofen treatment is associated with global behavioral improvement in fragile X syndrome (FXS: results of a randomized, controlled phase II trial. J Dev Behav Pediatr"},{"key":"17_CR236_17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.conb.2009.03.011","volume":"19","author":"M Waung","year":"2009","unstructured":"Waung M, Huber K (2009) Protein translation in synaptic plasticity: mGluR-LTD, Fragile X. Curr Opin Neurobiol 19:319\u2013326","journal-title":"Curr Opin Neurobiol"},{"key":"17_CR237_17","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1073\/pnas.94.10.5395","volume":"94","author":"I Weiler","year":"1997","unstructured":"Weiler I, Irwin S et al (1997) Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc Natl Acad Sci USA 94:5395\u20135400","journal-title":"Proc Natl Acad Sci USA"},{"key":"17_CR238_17","doi-asserted-by":"publisher","first-page":"17504","DOI":"10.1073\/pnas.0407533101","volume":"101","author":"I Weiler","year":"2004","unstructured":"Weiler I, Spangler C et al (2004) Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses. Proc Natl Acad Sci USA 101:17504\u201317509","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"17_CR239_17","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/ajmg.b.30765","volume":"147B","author":"N Weng","year":"2008","unstructured":"Weng N, Weiler IJ et al (2008) Early-phase ERK activation as a biomarker for metabolic status in fragile X syndrome. Am J Med Genet B Neuropsychiatr Genet 147B(7):1253\u20131257","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1\u20132","key":"17_CR240_17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.physbeh.2007.05.041","volume":"92","author":"H Westerberg","year":"2007","unstructured":"Westerberg H, Klingberg T (2007) Changes in cortical activity after training of working memory \u2013 a single-subject analysis. Physiol Behav 92(1\u20132):186\u2013192","journal-title":"Physiol Behav"},{"key":"17_CR241_17","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1073\/pnas.0610875104","volume":"104","author":"B Wilson","year":"2007","unstructured":"Wilson B, Cox C (2007) Absence of metabotropic glutamate receptor-mediated plasticity in the neocortex of fragile X mice. Proc Natl Acad Sci USA 104:2454\u20132459","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"17_CR242_17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5664\/jcsm.27443","volume":"5","author":"J Wirojanan","year":"2009","unstructured":"Wirojanan J, Jacquemont S et al (2009) The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome. J Clin Sleep Med 5(2):145\u2013150","journal-title":"J Clin Sleep Med"},{"key":"17_CR243_17","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/ajmg.1320380267","volume":"38","author":"K Wisniewski","year":"1991","unstructured":"Wisniewski K, Segan S et al (1991) The Fra(X) syndrome: neurological, electrophysiological, and neuropathological abnormalities. Am J Med Genet 38:476\u2013480","journal-title":"Am J Med Genet"},{"issue":"6","key":"17_CR244_17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1601-183X.2004.00087.x","volume":"3","author":"QJ Yan","year":"2004","unstructured":"Yan QJ, Asafo-Adjei PK et al (2004) A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse. Genes Brain Behav 3(6):337\u2013359","journal-title":"Genes Brain Behav"},{"key":"17_CR245_17","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.neuropharm.2005.06.004","volume":"49","author":"Q Yan","year":"2005","unstructured":"Yan Q, Rammal M et al (2005) Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.\". Neuropharmacology 49:1053\u20131066","journal-title":"Neuropharmacology"},{"key":"17_CR246_17","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.bbadis.2010.06.015","volume":"1802","author":"C Yuskaitis","year":"2010","unstructured":"Yuskaitis C, Beurel E et al (2010a) Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome. Biochim Biophys Acta 1802:1006\u20131012","journal-title":"Biochim Biophys Acta"},{"key":"17_CR247_17","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.bcp.2009.09.023","volume":"79","author":"C Yuskaitis","year":"2010","unstructured":"Yuskaitis C, Mines M et al (2010b) Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome. Biochem Pharmacol 79:632\u2013646","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"17_CR248_17","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nn1893","volume":"10","author":"F Zalfa","year":"2007","unstructured":"Zalfa F, Eleuteri B et al (2007) A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability. Nat Neurosci 10(5):578\u2013587","journal-title":"Nat Neurosci"},{"key":"17_CR249_17","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/gt.2009.83","volume":"16","author":"Z Zeier","year":"2009","unstructured":"Zeier Z, Kumar A et al (2009) Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome. Gene Ther 16:1122\u20131129","journal-title":"Gene Ther"},{"key":"17_CR250_17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1523\/JNEUROSCI.4515-03.2004","volume":"24","author":"W Zhao","year":"2004","unstructured":"Zhao W, Bianchi R et al (2004) Extracellular signal-regulated kinase 1\/2 is required for the induction of group I metabotropic glutamate receptor-mediated epileptiform discharges. J Neurosci 24:76\u201384","journal-title":"J Neurosci"},{"key":"17_CR251_17","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.1523\/JNEUROSCI.1520-05.2005","volume":"25","author":"M Zhao","year":"2005","unstructured":"Zhao M, Toyoda H et al (2005) Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome. J Neurosci 25:7385\u20137392","journal-title":"J Neurosci"}],"container-title":["Results and Problems in Cell Differentiation","Modeling Fragile X Syndrome"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-21649-7_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T14:59:32Z","timestamp":1686409172000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-21649-7_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,21]]},"ISBN":["9783642216480","9783642216497"],"references-count":251,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-21649-7_17","relation":{},"ISSN":["0080-1844","1861-0412"],"issn-type":[{"value":"0080-1844","type":"print"},{"value":"1861-0412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,21]]},"assertion":[{"value":"21 September 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}